Modular Edge Pods & AI Integration Reduce Deployment Risks for APAC Edge Centers

DUBLIN--(BUSINESS WIRE)--Jun 19, 2025--
The 'Asia-Pacific Edge Data Center Market: Focus on Product, Application, and Country Analysis - Analysis and Forecast, 2025-2034" report has been added to ResearchAndMarkets.com's offering.
The Asia-Pacific edge data center market, valued at $6.64 billion in 2024, is expected to reach $36.44 billion by 2034, exhibiting a robust CAGR of 17.99% during the forecast period 2025-2034.
An increasing trend towards low-latency, distributed computing architectures is propelling the APAC edge data-center market, especially as 5G networks, IoT deployments, and smart-city projects spread throughout the region. Edge sites provide millisecond-level response times for data-intensive use cases like autonomous cars, real-time video analytics, AR/VR apps, and industrial automation by relocating compute and storage capabilities closer to endpoints, relieving strain on centralised clouds and core networks.
Edge build-outs are becoming a top focus for governments and service providers, from China's 'New Infrastructure' program and South Korea's 5G+ Strategy to India's National Digital Communications Policy and Singapore's Smart Nation vision. Capex and opex for operators are being defrayed by subsidies for micro-data-center installations, spectrum allocations for private 5G networks, and advantageous tax treatment for local-build facilities.
The requirement for geographically dispersed compute nodes is further highlighted by the use cases' explosive expansion, which ranges from predictive maintenance in Japanese industry to precision agriculture in Australia.
Deployment risk is progressively declining due to continuous research and development in modular, prefabricated edge pods and sophisticated cooling solutions, even though issues with standardising hardware footprints, maintaining physical security at remote sites, and insuring multi-vendor interoperability still exist.
The region's next-generation digital economy will rely heavily on edge data centres as telcos and APAC businesses expand their commercial roll-outs and test programs.
APAC Edge Data Center Market Trends, Drivers and Challenges
Market Trends
Market Drivers
Market Challenges
Competitive Strategy:
Key players in the APAC edge data center market analyzed and profiled in the study include project developers and accounting tool providers. The analysis covers market segments by applications, products by type, regional presence, and the impact of key market strategies. Additionally, detailed competitive benchmarking has been conducted to illustrate how players compare, providing a clear view of the market landscape.
The study also examines comprehensive competitive strategies, such as partnerships, agreements, and collaborations, to help identify untapped revenue opportunities in the APAC edge data center market.
Key Attributes:
Key Topics Covered:
1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Trends Shaping Edge Data Center Market
1.1.2 5G Network Deployment
1.1.3 Proliferation of Internet of Things (IoT) Devices
1.1.4 Adoption of Software-Defined Networking (SDN) Technology
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.2.2 Market Map
1.2.2.1 Edge Data Center Market (by Type)
1.2.2.1.1 On-Premise Edge Providers
1.2.2.1.2 Network Edge Providers
1.2.2.1.3 Regional Edge Providers
1.3 Research and Development Review
1.4 Technological Analysis
1.4.1 Current and Upcoming Technologies
1.4.2 Key Countries with the Highest Number of Edge Deployments
1.4.3 Technologies at Risk of Becoming Obsolete
1.5 Implications for Investors, Operators, and Enterprises
1.6 Regulatory Landscape
1.7 Market Dynamics Overview
1.7.1 Market Drivers
1.7.1.1 Minimizing Latency and Bandwidth Usage
1.7.1.1.1 Case Study: Comparing Edge Servers and Cloud Locations for Enhanced User Experience
1.7.1.2 Increasing Focus on Providing Personalized AI Services
1.7.2 Market Restraints
1.7.2.1 Lack of Consideration of Security-by-Design
1.7.2.2 Non-Migratability of Security Frameworks
1.7.3 Market Opportunities
1.7.3.1 Surge in Investment by Data Center Providers
1.7.3.2 Increase in Data Generation
2 Regions
2.1 Regional Summary
2.2 Asia-Pacific
2.2.1 Key Market Participants in Asia-Pacific
2.2.2 Regional Overview
2.2.3 Driving Factors for Market Growth
2.2.4 Factors Challenging the Market
2.2.5 Application
2.2.6 Product
2.2.7 China
2.2.8 Application
2.2.9 Product
2.2.10 Japan
2.2.11 Application
2.2.12 Product
2.2.13 Australia
2.2.14 Application
2.2.15 Product
2.2.16 Rest-of-Asia-Pacific
2.2.17 Application
2.2.18 Product
3 Markets - Competitive Benchmarking & Company Profiles
3.1 Competitive Landscape
3.2 Company Profile
3.2.1 Leading Edge Data Centres
3.2.1.1 Overview
3.2.1.2 Top Products/Product Portfolio
3.2.1.3 Top Competitors
3.2.1.4 Target Customers
3.2.1.5 Key Personnel
3.2.1.6 Analyst View
3.2.1.7 Market Share
For more information about this report visit https://www.researchandmarkets.com/r/l9d35n
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250619907979/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: ASIA PACIFIC
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 06/19/2025 10:21 AM/DISC: 06/19/2025 10:21 AM
http://www.businesswire.com/news/home/20250619907979/en

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Associated Press

36 minutes ago

• Associated Press

SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit

BEIJING--(BUSINESS WIRE)--Jun 20, 2025-- SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ('Advantech/Prime') Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York. The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the 'Dissenting Investor Group') to wrest control of SINOVAC from its recently installed, lawfully-elected Board of Directors (the 'current SINOVAC Board') in accordance with the Privy Council order and Antiguan Law, and to interfere with the payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board. Following the New York court's ruling, the current SINOVAC Board is free to pursue its legal action in Antigua seeking to cancel the PIPE shares invalidly issued to the Dissenting Investor Group by the former illegitimate board (the 'Imposter Former Board'). If the current SINOVAC Board succeeds in legal proceedings on the PIPE shares, it has announced its intention to redistribute an additional US$11.00 per common share to SINOVAC's valid shareholders. Dr. Chiang Li, Chairman of the SINOVAC Board, commented, 'We will continue our mission to restore fairness and deliver value to all valid SINOVAC shareholders, starting with paying the $55.00 per share special cash dividend as soon as July 7, 2025.' The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy against SINOVAC has one goal: to prevent all valid SINOVAC common shareholders from receiving any dividend payments unless the Dissenting Investor Group receives an allocation for their invalid PIPE shares, despite the fact that they have already received over US$1 billion in dividends from a SINOVAC operating subsidiary. The current SINOVAC Board has set aside in escrow the pro rata portion of dividends for the PIPE shares — funds the Dissenting Investor Group could receive if the legal proceedings they initiated rule in their favor. The current SINOVAC Board is fighting back – and winning. We feel certain that we will prevail against any further legal action by the Dissenting Investor Group and look forward to ensuring all valid shareholders receive their fair share. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at [email protected]. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under 'Category 1 Preventative Biological Products' and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at [email protected]. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. View source version on CONTACT: Investor and Media Contact FGS Global [email protected] KEYWORD: CHINA UNITED STATES NORTH AMERICA ASIA PACIFIC NEW YORK INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH SOURCE: The Board of Directors of Sinovac Biotech Ltd. Copyright Business Wire 2025. PUB: 06/20/2025 10:56 PM/DISC: 06/20/2025 10:55 PM

Yahoo

an hour ago

• Yahoo

The Coca-Cola Company (KO) Teams Up with UMG to Launch Real Thing Records

The Coca-Cola Company (NYSE:KO) is one of the best stocks to buy. On June 11, Coca‑Cola announced a partnership with Universal Music Group to launch Real Thing Records (rtr), a music label to promote emerging global talent and foster greater engagement between artists and audiences. This collaboration represents Coca‑Cola's longstanding relationship with music. Adopting a genre-agnostic philosophy, rtr seeks to bring forward unique and authentic voices from around the world, positioning itself as a platform for the next generation of musical talent. The label's debut signings include Max Allais, a French-New Zealand artist, and Aksomaniac, an Indian singer-songwriter and producer. Pixabay/Public Domain Joshua Burke, Coca‑Cola's Global Head of Music & Culture, commented: 'The Coca‑Cola Company has a rich legacy, one of deep human connection and cultural resonance—breaking barriers and bringing people together across borders and generations. Real thing records is designed to unlock greater potential for artists, fans, and our brands—where creativity fuels growth, and the combined power of our network and key global music partners create value greater than the sum of its parts. It's our intention to let artists shine and give them the flexibility to develop their identities with the support of global reach and expertise. It's a long-term commitment to music—enabling us to reinvest in our programs, champion the next generation of talent, and stay rooted in what matters most: music and fandom." The Coca-Cola Company (NYSE:KO) is a global beverage corporation that produces and distributes carbonated soft drinks, bottled water, juices, teas, coffees, and plant-based beverages. While we acknowledge the potential of KO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

New York Times

2 hours ago

• New York Times

Air India C.E.O.'s Remarks After Plane Crash Draw Scrutiny

Campbell Wilson stood in a gray suit before a camera last week to read a carefully worded statement about the plane operated by Air India, the company he leads, that had crashed hours earlier in Ahmedabad, India, with 242 people aboard. His remarks immediately drew criticism. Social media users said he appeared cold and lacking in empathy. Soon after that, another critique emerged: Much of Mr. Wilson's speech was identical to one given five months earlier by Robert Isom, the chief executive of American Airlines, after a deadly crash in Washington. The similarities in the two statements are striking. Karthik Srinivasan, a communications consultant in Bengaluru, India, posted transcripts on social media showing that many of Mr. Campbell's words had exact parallels in Mr. Isom's. 'First and most importantly, I'd like to express our deep sorrow about these events,' Mr. Isom said in the video published Jan. 29. On June 12, Mr. Wilson began: 'First and most importantly, I would like to express our deep sorrow about this event.' 'This is a difficult day for all of us at American Airlines,' Mr. Isom continued. Mr. Wilson said: 'This is a difficult day for all of us at Air India.' Want all of The Times? Subscribe.